Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2009 1
2011 3
2012 5
2013 27
2014 21
2015 4
2016 2
2017 2
2018 1
2021 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 23734031

69 results

Results by year

Filters applied: . Clear all
Page 1
Canagliflozin approved for type 2 diabetes.
Traynor K. Traynor K. Am J Health Syst Pharm. 2013 May 15;70(10):834. doi: 10.2146/news130035. Am J Health Syst Pharm. 2013. PMID: 23640337 No abstract available.
Canagliflozin: a new drug for type 2.
Goldman-Levine J. Goldman-Levine J. Diabetes Self Manag. 2013 Jul-Aug;30(4):30, 32. Diabetes Self Manag. 2013. PMID: 23961597 No abstract available.
[Canagliflozin. For treating diabetes].
Sabourin G. Sabourin G. Perspect Infirm. 2013 May-Jun;10(3):59. Perspect Infirm. 2013. PMID: 23705284 French. No abstract available.
Canagliflozin: a new hope in the antidiabetic armamentarium.
Katsi VK, Michalakeas CA, Grassos CE, Vamvakou GD, Lekakis JP, Tousoulis D, Stefanadis CI, Makris TK, Kallikazaros IE. Katsi VK, et al. Recent Pat Cardiovasc Drug Discov. 2013 Dec;8(3):216-20. doi: 10.2174/1574890108666131213100613. Recent Pat Cardiovasc Drug Discov. 2013. PMID: 24359233 Review.
Drug approved for type 2 diabetes.
[No authors listed] [No authors listed] Nurs Times. 2014 Jul 2-8;110(27):4. Nurs Times. 2014. PMID: 25095559 No abstract available.
Canagliflozin, alogliptin benzoate, and ospemifene.
Hussar DA, Frimpong JO. Hussar DA, et al. J Am Pharm Assoc (2003). 2013 Jul-Aug;53(4):442-7. doi: 10.1331/JAPhA.2013.13527. J Am Pharm Assoc (2003). 2013. PMID: 23892821 No abstract available.
69 results